PROSENSA

Prosensa is a biotech company also known as Ribpharm Inc dedicated to the commercialization of products for the healthcare market based on RNA-based therapeutics. During the development of this technology, it became clear that many opportunities exist for the development of these products into novel commercially attractive products. These products are mainly in the field of genetic disorders, anti-infectives and oncology. Prosensa will focus to maximize the commercial development of the current program, and take advantage of the large novel market opportunities supported by a strong IP position. Prosensa will initially operate mainly as a focussed company, outsourcing most of its activities to specialized organizations.

#SimilarOrganizations #People #Financial #Website #More

PROSENSA

Social Links:

Facebook

Twitter

Industry:

Biotechnology Genetics Health Care Medical Therapeutics

Founded:

2002-01-01

Address:

Leiden, Zuid-Holland, The Netherlands

Country:

The Netherlands

Website Url:

http://www.prosensa.eu

Total Employee:

11+

Status:

Active

Contact:

866.906.6100

Email Addresses:

[email protected]

Total Funding:

73.95 M USD

Technology used in webpage:

Domain Not Resolving Google Maps GStatic Google Static Content Drupal DNS Made Easy DNS

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

nanotherics-logo

nanoTherics

nanoTherics offers IP-protected products that support the field of magnetic nanoparticle research and applications.

smart-cells-logo

Smart Cells

Smart Cells provides stored stem cell units for use in the treatment of children with life-threatening illnesses.

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

vaxira-logo

Vaxira

Vaxira is a therapeutic vaccine for the treatment of non-small cell lung cancer

Current Advisors List

remi-droller_image

Remi Droller Member of the Board of Directors @ Prosensa
Board_member
2008-01-01

martijn-kleijwegt_image

Martijn Kleijwegt Supervisory Board member @ Prosensa
Board_member
2008-01-01

david-mott_image

David Mott Board Member @ Prosensa
Board_member

sara-nayeem_image

Sara Nayeem Investor @ Prosensa
Board_member

georges-gemayel_image

Georges Gemayel Member of the Supervisory Board @ Prosensa
Board_member
2014-01-01

stephen-bunting_image

Stephen Bunting Supervisory Board member @ Prosensa
Board_member

david-mott_image

David Mott Chairman @ Prosensa
Board_member

jim-van-heusden_image

Jim Van heusden Supervisory Board member @ Prosensa
Board_member

Current Employees Featured

daan-ellens_image

Daan Ellens
Daan Ellens Supervisory Board member @ Prosensa
Supervisory Board member

judith-van-deutekom_image

Judith van Deutekom
Judith van Deutekom Vice-President Drug Discovery @ Prosensa
Vice-President Drug Discovery

not_available_image

Roelck A Cuperus
Roelck A Cuperus VP Regulatory Affairs @ Prosensa
VP Regulatory Affairs
2008-12-01

richard-h-holslag_image

Richard H Holslag
Richard H Holslag VP Manufacturing @ Prosensa
VP Manufacturing
2009-01-01

giles-campion_image

Giles Campion
Giles Campion Chief Medical Officer & Senior Vice-President R&D @ Prosensa
Chief Medical Officer & Senior Vice-President R&D
2009-01-01

hans-gcp-schikan_image

Hans GCP Schikan
Hans GCP Schikan Chief Executive Officer @ Prosensa
Chief Executive Officer
2009-01-01

Stock Details

Company's stock symbol is NASDAQ:RNA

Investors List

parent-project-muscular-dystrophy_image

Investments List

Date	Company	Article	Money raised
2012-01-25	Prosensa	Prosensa investment in Venture Round - Prosensa	23 M EUR

Official Site Inspections

http://www.prosensa.eu

Host Informations
Whois Informations

Loading ...